Search Results - "Gladbach, Yvonne"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Identification of novel diabetes impaired miRNA-transcription factor co-regulatory networks in bone marrow-derived Lin-/VEGF-R2+ endothelial progenitor cells by Irhimeh, Mohammad R, Hamed, Mohamed, Barthelmes, Daniel, Gladbach, Yvonne, Helms, Volkhard, Shen, Weiyong, Gillies, Mark C

    Published in PloS one (11-07-2018)
    “…Endothelial progenitor cells (EPCs) are a group of rare cells that play an important role in the repair of injured vascular endothelial cells and assist in…”
    Get full text
    Journal Article
  2. 2

    In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters by Salewski, Inken, Gladbach, Yvonne Saara, Kuntoff, Steffen, Irmscher, Nina, Hahn, Olga, Junghanss, Christian, Maletzki, Claudia

    Published in Journal of translational medicine (21-10-2020)
    “…Cancer vaccines provide a complex source of neoantigens. Still, increasing evidence reveals that the neoantigen quality rather than the quantity is predictive…”
    Get full text
    Journal Article
  3. 3

    Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia by Richter, Anna, Roolf, Catrin, Hamed, Mohamed, Gladbach, Yvonne Saara, Sender, Sina, Konkolefski, Christoph, Knübel, Gudrun, Sekora, Anett, Fuellen, Georg, Vollmar, Brigitte, Murua Escobar, Hugo, Junghanss, Christian

    Published in BMC cancer (06-03-2019)
    “…The tumor suppressor protein phosphatase and tensin homolog (PTEN) is a key regulator of the PI3K/AKT pathway which is frequently altered in a variety of…”
    Get full text
    Journal Article
  4. 4

    Cellular vaccination of MLH1−/− mice - an immunotherapeutic proof of concept study by Maletzki, Claudia, Gladbach, Yvonne Saara, Hamed, Mohamed, Fuellen, Georg, Semmler, Marie-Luise, Stenzel, Jan, Linnebacher, Michael

    Published in Oncoimmunology (04-03-2018)
    “…Mismatch-repair deficiency (MMR-D) is closely linked to hypermutation and accordingly, high immunogenicity. MMR-D-related tumors thus constitute ideal…”
    Get full text
    Journal Article
  5. 5

    Identification of novel diabetes impaired miRNA-transcription factor co-regulatory networks in bone marrow-derived Lin.sup.-/VEGF-R2.sup.+ endothelial progenitor cells by Irhimeh, Mohammad R, Hamed, Mohamed, Barthelmes, Daniel, Gladbach, Yvonne, Helms, Volkhard, Shen, Weiyong, Gillies, Mark C

    Published in PloS one (11-07-2018)
    “…Endothelial progenitor cells (EPCs) are a group of rare cells that play an important role in the repair of injured vascular endothelial cells and assist in…”
    Get full text
    Journal Article
  6. 6

    A workflow for the integrative transcriptomic description of molecular pathology and the suggestion of normalizing compounds, exemplified by Parkinson’s disease by Hamed, Mohamed, Gladbach, Yvonne, Möller, Steffen, Fischer, Sarah, Ernst, Mathias, Struckmann, Stephan, Storch, Alexander, Fuellen, Georg

    Published in Scientific reports (21-05-2018)
    “…The volume of molecular observations on human diseases in public databases is continuously increasing at accelerating rates. A bottleneck is their…”
    Get full text
    Journal Article
  7. 7

    Unraveling the Heterogeneous Mutational Signature of Spontaneously Developing Tumors in MLH1−/− Mice by Gladbach, Yvonne Saara, Wiegele, Leonie, Hamed, Mohamed, Merkenschläger, Anna-Marie, Fuellen, Georg, Junghanss, Christian, Maletzki, Claudia

    Published in Cancers (02-10-2019)
    “…Mismatch repair deficient (MMR-D) tumors exemplify the prototypic hypermutator phenotype. Owing to the high mutation rates, plenty of neo-antigens are present…”
    Get full text
    Journal Article
  8. 8

    Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse by Gladbach, Yvonne Saara, Sklarz, Lisa-Madeleine, Roolf, Catrin, Beck, Julia, Schütz, Ekkehard, Fuellen, Georg, Junghanss, Christian, Murua Escobar, Hugo, Hamed, Mohamed

    Published in Genes (14-07-2022)
    “…Little is known about optimally applying chemotherapeutic agents in a specific temporal sequence to rapidly reduce the tumor load and to improve therapeutic…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11